By leveraging our proprietary AI algorithms and curated multi-omics datasets, we enable clinicians and researchers to make data-driven decisions in oncology, neurology, and rare diseases. We are currently developing AI-driven panels for early detection and stratification of complex diseases using population-scale omics data. See more